Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statementWilson I. Gonsalves, Vivek Roy, Jeremy T. Larsen et al.|Bone Marrow Transplantation|2018Cited by 116
Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 UpdateEli Muchtar, Taimur Sher, Angela Dispenzieri et al.|Mayo Clinic Proceedings|2021Cited by 86
“Real-life” data of the efficacy and safety of belantamab mafodotin in relapsed multiple myeloma—the Mayo Clinic experienceIuliana Vaxman, Morie A. Gertz, Jithma P. Abeykoon et al.|Blood Cancer Journal|2021Cited by 49
Assessment of fixed‐duration therapies for treatment‐naïve <scp>Waldenström</scp> macroglobulinemiaJithma P. Abeykoon, Prashant Kapoor, Saurabh Zanwar et al.|American Journal of Hematology|2021Cited by 25
Efficacy of Daratumumab-Based Regimens for the Treatment of Plasma Cell LeukemiaRicardo Parrondo, Sikander Ailawadhi, Muhamad Alhaj Moustafa et al.|Clinical Lymphoma Myeloma & Leukemia|2021Cited by 17